[Endovascular therapy for femoral-popliteal disease].
Endovascular revascularization in femoropopliteal disease is indicated for symptomatic patients who do not respond adequately to pharmacotherapy and supervised exercise therapy, and for those who present critical limb ischemia. There are no absolute contraindications to endovascular intervention, and endovascular therapy is the initial therapy of choice in symptomatic patients with PAD because it avoids the morbidity associated with vascular surgery. Treatment of claudication is directed towards symptom relief and restoration of limb function, whereas treatment of critical limb ischemia is directed towards limb salvage.